SPDR® Solactive United Kingdom ETF (ZGBR)

50.46 -1.11  -2.14% NYSE Arca Jan 27, 20:00 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 50.45
Discount or Premium to NAV 0.03%
Turnover Ratio 13.00%
1 Year Fund Level Flows 2.334M
View All ZGBR News

News

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -3.30% -3.37% -- --
3M 3.09% 3.18% -- --
6M 3.94% 4.90% -- --
YTD -3.49% -3.23% -- --
1Y 12.05% 12.02% -- --
3Y 6.86% 6.96% -- --
5Y 3.36% 2.23% -- --
10Y -- -- -- --
15Y -- -- -- --
20Y -- -- -- --
As of Jan. 27, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.21% 0.21% 0.00%
Stock 99.79% 99.79% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Jan. 24, 2020

Region Exposure

Americas 2.64%
North America 2.57%
Latin America 0.06%
Greater Europe 97.36%
United Kingdom 97.06%
Europe Developed 0.00%
Europe Emerging 0.30%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 99.64%
% Emerging Markets 0.36%
As of Jan. 24, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 7.32%
Communication Services 7.57%
Consumer Cyclical 6.77%
Consumer Defensive 17.58%
Energy 15.09%
Financial Services 19.58%
Healthcare 11.51%
Industrials 8.91%
Real Estate 1.19%
Technology 0.80%
Utilities 3.69%
As of Jan. 24, 2020

Stock Market Capitalization

Giant 44.32%
Large 35.53%
Medium 20.15%
Small 0.00%
Micro 0.00%
As of Jan. 24, 2020

Stock Style Exposure

Large Cap Value 38.06%
Large Cap Blend 36.89%
Large Cap Growth 4.91%
Mid Cap Value 5.65%
Mid Cap Blend 8.56%
Mid Cap Growth 5.94%
Small Cap Value 0.00%
Small Cap Blend 0.00%
Small Cap Growth 0.00%
As of Jan. 24, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
HSBA HSBC Holdings PLC 6.21% -- --
AZN AstraZeneca PLC 5.31% -- --
BP. BP PLC 5.25% -- --
GSK GlaxoSmithKline PLC 4.81% -- --
RDSA Royal Dutch Shell PLC Class A 4.77% -- --
RDSB Royal Dutch Shell PLC B 4.33% -- --
BATS British American Tobacco PLC 4.14% -- --
DGE Diageo PLC 4.04% -- --
ULVR Unilever PLC 2.61% -- --
RIO Rio Tinto PLC 2.51% -- --
As of Jan. 24, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks to track the performance of the Solactive GBS United Kingdom Large & Mid Cap Index. The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index and in depositary receipts based on securities comprising the index. The index is a free float-adjusted market capitalization index that is designed to measure the equity market performance of large- and mid-cap companies in the United Kingdom. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Value
Fixed Income Style --
Broad Asset Class International Equity
Broad Category Equity
Category Name Miscellaneous Region
Prospectus Objective Foreign Stock
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
Solactive GBS UK Lar&Mid Cap NR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Karl Schneider 4.75 yrs
Michael Feehily 5.39 yrs
Olga Winner 2.82 yrs

Net Fund Flows

1M 0.00
3M 1.250M
6M 3.623M
YTD 2.334M
1Y 2.334M
3Y 10.18M
5Y 7.326M
10Y --
As of Dec. 31, 2019

Risk Info

Beta (5Y) 0.9629
Max Drawdown (All) 24.60%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 0.0238
30-Day Rolling Volatility 14.40%
Daily Value at Risk (VaR) 1% (All) 2.90%
Monthly Value at Risk (VaR) 1% (All) 8.75%

Fundamentals

Dividend Yield TTM (1-27-20) 4.69%
30-Day SEC Yield (12-31-19) 4.38%
7-Day SEC Yield --
Weighted Average PE Ratio 15.93
Weighted Average Price to Sales Ratio 1.171
Weighted Average Price to Book Ratio 1.720
Weighted Median ROE 20.49%
Weighted Median ROA 5.41%
Forecasted Dividend Yield 4.56%
Forecasted PE Ratio 13.36
Forecasted Price to Sales Ratio 1.074
Forecasted Price to Book Ratio 1.385
Number of Holdings 107
As of Jan. 24, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 7.40%
Forecasted Book Value Growth 6.60%
Forecasted Cash Flow Growth 7.01%
Forecasted Earnings Growth 7.38%
Forecasted Revenue Growth 3.30%
As of Jan. 24, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 6/11/2014
Termination Date
Last Annual Report Date 9/30/2019
Last Prospectus Date 1/31/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.